Yili Chuanning Biotechnology Co.,Ltd. (SHE:301301)

SHE:301301 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Cash & Equivalents	952.64	1,088	760.94	1,632	510.05	510.2
Trading Asset Securities	190.33	-	-	1.15	1.21	0.42
Cash & Short-Term Investments	1,143	1,088	760.94	1,633	511.26	510.62
Cash Growth	28.46%	43.03%	-53.41%	219.44%	0.13%	192.94%
Accounts Receivable	1,939	1,572	1,403	1,417	1,178	1,220
Other Receivables	0.86	0.53	0.63	2.59	1.19	1.73
Receivables	1,940	1,573	1,404	1,420	1,179	1,222
Inventory	1,167	1,342	1,676	1,384	1,453	1,449
Other Current Assets	166.95	141.02	114.94	91.25	72.12	134.88
Total Current Assets	4,416	4,144	3,956	4,528	3,216	3,316
Property, Plant & Equipment	5,934	6,046	5,870	5,539	5,920	6,293
Long-Term Investments	92.78	70.69	6.78	6.93	-	-
Goodwill	1.37	1.37	1.37	1.37	1.37	1.37
Other Intangible Assets	231.04	235.83	257.99	283.07	271.83	211.54
Long-Term Deferred Tax Assets	22.31	20.9	21.65	11.34	6.96	4.02
Long-Term Deferred Charges	2.32	1.54	2.42	3.4	4.72	39.93
Other Long-Term Assets	32.67	33.25	21.64	17.97	40.94	54.46
Total Assets	10,733	10,554	10,139	10,390	9,462	9,920
Accounts Payable	803.12	383.33	479.98	282.99	427.66	420.63
Accrued Expenses	27.32	64.32	31.57	66.32	20.7	23.09
Short-Term Debt	210.15	210.15	850.68	978.83	700.35	790.75
Current Portion of Long-Term Debt	740.58	608.16	538.36	847.26	878.17	628.27
Current Portion of Leases	-	8.9	3.8	1.88	1.02	-
Current Income Taxes Payable	132.36	66.37	36.52	24.79	0.14	0.17
Current Unearned Revenue	27.01	66.82	28.94	38	21.26	15.78
Other Current Liabilities	31.53	539.49	565.85	467.33	513.58	521.87
Total Current Liabilities	1,972	1,948	2,536	2,707	2,563	2,401
Long-Term Debt	-	146	357.33	1,428	2,092	2,846
Long-Term Leases	455.67	451.12	188.12	10.2	3.13	-
Long-Term Unearned Revenue	94.56	92.51	83.74	34.24	26.22	7.92
Long-Term Deferred Tax Liabilities	-	-	0.31	0.08	-	-
Other Long-Term Liabilities	3.04	-	0.08	-	-	-
Total Liabilities	2,525	2,637	3,165	4,180	4,684	5,254
Common Stock	2,227	2,227	2,223	2,223	2,000	2,000
Additional Paid-In Capital	3,287	3,284	3,252	3,229	2,431	2,431
Retained Earnings	2,674	2,386	1,486	752.21	340.7	229.35
Comprehensive Income & Other	-0.1	-0.1	-	-	-	-
Total Common Equity	8,188	7,898	6,960	6,204	4,771	4,660
Minority Interest	18.82	18.83	12.87	6	6	6
Shareholders' Equity	8,207	7,916	6,973	6,210	4,777	4,666
Total Liabilities & Equity	10,733	10,554	10,139	10,390	9,462	9,920
Total Debt	1,406	1,424	1,938	3,266	3,675	4,265
Net Cash (Debt)	-263.43	-336	-1,177	-1,633	-3,163	-3,754
Net Cash Per Share	-0.12	-0.15	-0.53	-0.83	-1.70	-1.88
Filing Date Shares Outstanding	2,227	2,227	2,223	2,223	2,000	2,000
Total Common Shares Outstanding	2,227	2,227	2,223	2,223	2,000	2,000
Working Capital	2,444	2,197	1,421	1,820	653.24	915.35
Book Value Per Share	3.68	3.55	3.13	2.79	2.39	2.33
Tangible Book Value	7,956	7,660	6,701	5,920	4,498	4,447
Tangible Book Value Per Share	3.57	3.44	3.01	2.66	2.25	2.22
Buildings	-	3,060	2,779	2,637	2,560	2,461
Machinery	-	6,226	5,861	5,815	5,725	5,449
Construction In Progress	-	285.31	537.8	60.12	96.38	356.08

Source: S&P Global Market Intelligence. Standard template. Financial Sources.